Utility of radiomic features in predicting clinical outcomes in stage II-III pancreatic cancer.

H Itakura, Q Xu, D Toesca, L Vitzthum, A Jamalian… - 2024 - ascopubs.org
74 Background: We identified computed tomography (CT)-derived radiomic features
predictive of tumor progression within three months, then examined their ability to …

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

Q Xu, DA Santos Toesca, E Schueler, A Jamalian… - 2024 - ascopubs.org
706 Background: We sought to assess the ability of a computed tomography (CT)-derived
radiomic signature (RS) feature set to predict rapid tumor progression and overall survival …

[HTML][HTML] Radiomics-based outcome prediction for pancreatic cancer following stereotactic body radiotherapy

E Parr, Q Du, C Zhang, C Lin, A Kamal, J McAlister… - Cancers, 2020 - mdpi.com
(1) Background: Radiomics use high-throughput mining of medical imaging data to extract
unique information and predict tumor behavior. Currently available clinical prediction …

[HTML][HTML] 172P Survival prediction using CT based radiomic features in patients of pancreatic cancer treated by chemotherapy followed by SBRT: A pilot study

D Khosla, G Singh, R Kapoor, V Thakur, A Oinam… - ESMO Open, 2023 - esmoopen.com
Background Pancreatic cancer is a disease with poor prognosis. Stereotactic body radiation
therapy (SBRT) is emerging hope to achieve better resectability and local control. Pancreatic …

[HTML][HTML] Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma

L Cozzi, T Comito, A Fogliata, C Franzese… - PloS one, 2019 - journals.plos.org
Purpose To appraise the ability of a radiomics signature to predict clinical outcome after
stereotactic body radiation therapy (SBRT) for pancreas carcinoma. Methods A cohort of 100 …

[引用][C] Radiomics-Based Survival and Recurrence Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy

E Parr, Q Du, C Zhang, C Lin, A Kamal… - International Journal of …, 2020 - redjournal.org
Results Patients were clustered into 4 clusters with the radiomic expression patterns and
compared against clinical parameters, with association found only with resection status (p …

Quantitative analysis of 18F-fluorodeoxyglucose positron emission tomography identifies novel prognostic imaging biomarkers in locally advanced pancreatic cancer …

Y Cui, J Song, E Pollom, M Alagappan… - International Journal of …, 2016 - Elsevier
Purpose To identify prognostic biomarkers in pancreatic cancer using high-throughput
quantitative image analysis. Methods and Materials In this institutional review board …

Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy

F Gregucci, A Fiorentino, R Mazzola, F Ricchetti… - La radiologia …, 2022 - Springer
Purpose Aim of this study is to assess the ability of contrast-enhanced CT image-based
radiomic analysis to predict local response (LR) in a retrospective cohort of patients affected …

Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions

C Yu, Y Ruan, L Yu, X Wang, Z Hu, G Zhu… - Journal of …, 2024 - Elsevier
background Computed tomography (CT) imaging has the potential to assist in predicting the
prognosis and treatment strategies for pancreatic cancer (PC). This study aimed to develop …

Clinical determinants of survival in patients with stage II-III pancreatic cancer.

H Itakura, Q Xu, D Toesca, L Vitzthum, A Jamalian… - 2024 - ascopubs.org
56 Background: We sought to identify the clinical determinants of overall survival (OS) in
patients diagnosed with stage II-III pancreatic cancer not undergoing surgery. We curated a …